单纯性肾囊肿手术治疗的安全共识

2020-08-20 中国医促会泌尿健康促进分会 现代泌尿外科杂志.2020.25(8):665-675.

随着微创技术的推广和普及,单纯性肾囊肿主要以微创治疗为主。包括超声引导下囊肿穿刺引流硬化术、经腹腔或经腹膜后腔单孔或多孔腹腔镜肾囊肿去顶减压术及近年开展的输尿管软镜内切开引流术、经皮肾镜肾囊肿去顶减压

中文标题:

单纯性肾囊肿手术治疗的安全共识

发布日期:

2020-08-20

简要介绍:

随着微创技术的推广和普及,单纯性肾囊肿主要以微创治疗为主。包括超声引导下囊肿穿刺引流硬化术、经腹腔或经腹膜后腔单孔或多孔腹腔镜肾囊肿去顶减压术及近年开展的输尿管软镜内切开引流术、经皮肾镜肾囊肿去顶减压术等,开放性手术已基本淘汰。上述几种微创手术方式在各级医院均有不同程度的开展,本共识将从条件保障、人员培训、规范操作、并发症防治和患者管理等方面,从多角度推荐上述几种常见的肾囊肿手术的安全准则,希望为从业者的临床实践提供参考。本次讨论的单纯性肾囊肿主要指Bosniak分级中Ⅰ级、Ⅱ级及ⅡF级囊肿,Ⅲ级和Ⅳ级囊肿不在本次讨论范围内。

相关资料下载:
[AttachmentFileName(sort=1, fileName=单纯性肾囊肿手术治疗的安全共识_陈兴发.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8a27b1c0019588d8, title=单纯性肾囊肿手术治疗的安全共识, enTitle=, guiderFrom=现代泌尿外科杂志.2020.25(8):665-675., authorId=0, author=, summary=随着微创技术的推广和普及,单纯性肾囊肿主要以微创治疗为主。包括超声引导下囊肿穿刺引流硬化术、经腹腔或经腹膜后腔单孔或多孔腹腔镜肾囊肿去顶减压术及近年开展的输尿管软镜内切开引流术、经皮肾镜肾囊肿去顶减压, cover=https://img.medsci.cn/2020830/1598721706608_2020535.jpg, journalId=0, articlesId=null, associationId=1623, associationName=中国医促会泌尿健康促进分会, associationIntro=, copyright=0, guiderPublishedTime=Thu Aug 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>随着微创技术的推广和普及,单纯性肾囊肿主要以微创治疗为主。包括超声引导下囊肿穿刺引流硬化术、经腹腔或经腹膜后腔单孔或多孔腹腔镜肾囊肿去顶减压术及近年开展的输尿管软镜内切开引流术、经皮肾镜肾囊肿去顶减压术等,开放性手术已基本淘汰。上述几种微创手术方式在各级医院均有不同程度的开展,本共识将从条件保障、人员培训、规范操作、并发症防治和患者管理等方面,从多角度推荐上述几种常见的肾囊肿手术的安全准则,希望为从业者的临床实践提供参考。本次讨论的单纯性肾囊肿主要指Bosniak分级中Ⅰ级、Ⅱ级及ⅡF级囊肿,Ⅲ级和Ⅳ级囊肿不在本次讨论范围内。</p> </div> </div> </div>, tagList=[TagDto(tagId=62991, tagName=肾囊肿)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=62991, guiderKeyword=肾囊肿, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3097, appHits=195, showAppHits=0, pcHits=955, showPcHits=2901, likes=1, shares=7, comments=7, approvalStatus=1, publishedTime=Sun Aug 30 01:28:54 CST 2020, publishedTimeString=2020-08-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 30 01:21:57 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 08:58:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=单纯性肾囊肿手术治疗的安全共识_陈兴发.pdf)])
单纯性肾囊肿手术治疗的安全共识_陈兴发.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1015223, encodeId=72c810152232a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Sep 07 01:06:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997686, encodeId=7f7c99e68646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23425457945, createdName=ms6000000468217277, createdTime=Thu Jul 08 21:09:06 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945155, encodeId=0271945155f7, content=超微创, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/14a81e233ddc44ebbd546a6376cdb33e/9b1eeca21f644ab4979394422ff645de.jpg, createdBy=b87d2058022, createdName=1851ed3e5dm, createdTime=Wed Mar 03 15:42:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898262, encodeId=48ea89826213, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XbOhiaFWR0msI6gibIefsoG5WEIkLQtJibbNsr5rdwtjLp7a3hVYiaT7cVCuWcxEqiaMHSGDD542f6vwicxwmQ4t5arQ/132, createdBy=b3f25247263, createdName=胖偲, createdTime=Tue Nov 10 16:10:37 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891628, encodeId=fec889162829, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/bcb1af8f2a2f47deba30a739cf924982/c7aa99532b064c7b872e9782421930cd.jpg, createdBy=70f21490467, createdName=dongpeihong1968, createdTime=Mon Oct 12 22:02:28 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
    2021-09-07 ms5000001266883663

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1015223, encodeId=72c810152232a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Sep 07 01:06:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997686, encodeId=7f7c99e68646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23425457945, createdName=ms6000000468217277, createdTime=Thu Jul 08 21:09:06 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945155, encodeId=0271945155f7, content=超微创, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/14a81e233ddc44ebbd546a6376cdb33e/9b1eeca21f644ab4979394422ff645de.jpg, createdBy=b87d2058022, createdName=1851ed3e5dm, createdTime=Wed Mar 03 15:42:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898262, encodeId=48ea89826213, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XbOhiaFWR0msI6gibIefsoG5WEIkLQtJibbNsr5rdwtjLp7a3hVYiaT7cVCuWcxEqiaMHSGDD542f6vwicxwmQ4t5arQ/132, createdBy=b3f25247263, createdName=胖偲, createdTime=Tue Nov 10 16:10:37 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891628, encodeId=fec889162829, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/bcb1af8f2a2f47deba30a739cf924982/c7aa99532b064c7b872e9782421930cd.jpg, createdBy=70f21490467, createdName=dongpeihong1968, createdTime=Mon Oct 12 22:02:28 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
    2021-07-08 ms6000000468217277

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1015223, encodeId=72c810152232a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Sep 07 01:06:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997686, encodeId=7f7c99e68646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23425457945, createdName=ms6000000468217277, createdTime=Thu Jul 08 21:09:06 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945155, encodeId=0271945155f7, content=超微创, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/14a81e233ddc44ebbd546a6376cdb33e/9b1eeca21f644ab4979394422ff645de.jpg, createdBy=b87d2058022, createdName=1851ed3e5dm, createdTime=Wed Mar 03 15:42:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898262, encodeId=48ea89826213, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XbOhiaFWR0msI6gibIefsoG5WEIkLQtJibbNsr5rdwtjLp7a3hVYiaT7cVCuWcxEqiaMHSGDD542f6vwicxwmQ4t5arQ/132, createdBy=b3f25247263, createdName=胖偲, createdTime=Tue Nov 10 16:10:37 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891628, encodeId=fec889162829, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/bcb1af8f2a2f47deba30a739cf924982/c7aa99532b064c7b872e9782421930cd.jpg, createdBy=70f21490467, createdName=dongpeihong1968, createdTime=Mon Oct 12 22:02:28 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
    2021-03-03 1851ed3e5dm

    超微创

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1015223, encodeId=72c810152232a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Sep 07 01:06:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997686, encodeId=7f7c99e68646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23425457945, createdName=ms6000000468217277, createdTime=Thu Jul 08 21:09:06 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945155, encodeId=0271945155f7, content=超微创, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/14a81e233ddc44ebbd546a6376cdb33e/9b1eeca21f644ab4979394422ff645de.jpg, createdBy=b87d2058022, createdName=1851ed3e5dm, createdTime=Wed Mar 03 15:42:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898262, encodeId=48ea89826213, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XbOhiaFWR0msI6gibIefsoG5WEIkLQtJibbNsr5rdwtjLp7a3hVYiaT7cVCuWcxEqiaMHSGDD542f6vwicxwmQ4t5arQ/132, createdBy=b3f25247263, createdName=胖偲, createdTime=Tue Nov 10 16:10:37 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891628, encodeId=fec889162829, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/bcb1af8f2a2f47deba30a739cf924982/c7aa99532b064c7b872e9782421930cd.jpg, createdBy=70f21490467, createdName=dongpeihong1968, createdTime=Mon Oct 12 22:02:28 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
    2020-11-10 胖偲

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1015223, encodeId=72c810152232a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Sep 07 01:06:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997686, encodeId=7f7c99e68646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23425457945, createdName=ms6000000468217277, createdTime=Thu Jul 08 21:09:06 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945155, encodeId=0271945155f7, content=超微创, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210303/14a81e233ddc44ebbd546a6376cdb33e/9b1eeca21f644ab4979394422ff645de.jpg, createdBy=b87d2058022, createdName=1851ed3e5dm, createdTime=Wed Mar 03 15:42:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898262, encodeId=48ea89826213, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XbOhiaFWR0msI6gibIefsoG5WEIkLQtJibbNsr5rdwtjLp7a3hVYiaT7cVCuWcxEqiaMHSGDD542f6vwicxwmQ4t5arQ/132, createdBy=b3f25247263, createdName=胖偲, createdTime=Tue Nov 10 16:10:37 CST 2020, time=2020-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891628, encodeId=fec889162829, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201012/bcb1af8f2a2f47deba30a739cf924982/c7aa99532b064c7b872e9782421930cd.jpg, createdBy=70f21490467, createdName=dongpeihong1968, createdTime=Mon Oct 12 22:02:28 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
    2020-10-12 dongpeihong1968

    0